ID,Description,setSize,enrichmentScore,NES,pvalue,p.adjust,qvalues,ont,comparison
GO:0005759,mitochondrial matrix,369,-0.388095641140313,-1.73447333182172,0.00353356890459364,0.0377005347593583,0.0284266816774557,CC,mono-rr-vs-hc
GO:0019866,organelle inner membrane,471,-0.290243337328943,-1.34282530690743,0.00371747211895911,0.0377005347593583,0.0284266816774557,CC,mono-rr-vs-hc
GO:0005743,mitochondrial inner membrane,427,-0.305904285235882,-1.40356394642213,0.00374531835205993,0.0377005347593583,0.0284266816774557,CC,mono-rr-vs-hc
GO:0005840,ribosome,209,-0.363647584310295,-1.5584822454768,0.00377358490566038,0.0377005347593583,0.0284266816774557,CC,mono-rr-vs-hc
GO:0005777,peroxisome,116,-0.378497757522299,-1.4943136137282,0.00384615384615385,0.0377005347593583,0.0284266816774557,CC,mono-rr-vs-hc
GO:0042579,microbody,116,-0.378497757522299,-1.4943136137282,0.00384615384615385,0.0377005347593583,0.0284266816774557,CC,mono-rr-vs-hc
GO:0030055,cell-substrate junction,358,0.322929820876567,1.48246466962896,0.00396825396825397,0.0377005347593583,0.0284266816774557,CC,mono-rr-vs-hc
GO:0000785,chromatin,388,0.291451435544333,1.33947016594687,0.004,0.0377005347593583,0.0284266816774557,CC,mono-rr-vs-hc
GO:0005911,cell-cell junction,288,0.327458978889504,1.45498094245002,0.00408163265306122,0.0377005347593583,0.0284266816774557,CC,mono-rr-vs-hc
GO:0005925,focal adhesion,351,0.324496241381106,1.48451276298918,0.00408163265306122,0.0377005347593583,0.0284266816774557,CC,mono-rr-vs-hc
GO:0005924,cell-substrate adherens junction,354,0.323953276346346,1.4786365830779,0.00418410041841004,0.0377005347593583,0.0284266816774557,CC,mono-rr-vs-hc
GO:0000151,ubiquitin ligase complex,240,-0.335415043616349,-1.47396939141823,0.00436681222707424,0.0377005347593583,0.0284266816774557,CC,mono-rr-vs-hc
GO:0030880,RNA polymerase complex,119,-0.429110598087112,-1.7269214566779,0.00444444444444444,0.0377005347593583,0.0284266816774557,CC,mono-rr-vs-hc
GO:0000428,DNA-directed RNA polymerase complex,118,-0.42664924253013,-1.71501795756812,0.00446428571428571,0.0377005347593583,0.0284266816774557,CC,mono-rr-vs-hc
GO:0055029,nuclear DNA-directed RNA polymerase complex,118,-0.42664924253013,-1.71501795756812,0.00446428571428571,0.0377005347593583,0.0284266816774557,CC,mono-rr-vs-hc
GO:0005912,adherens junction,413,0.317261305187172,1.46129539947638,0.00452488687782805,0.0377005347593583,0.0284266816774557,CC,mono-rr-vs-hc
GO:0070161,anchoring junction,426,0.32228035830265,1.49148659880119,0.00454545454545455,0.0377005347593583,0.0284266816774557,CC,mono-rr-vs-hc
GO:0001228,transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,210,0.330806378140853,1.4537334989912,0.00381679389312977,0.0495513070620367,0.0357311538698482,MF,mono-rr-vs-hc
GO:0015077,monovalent inorganic cation transmembrane transporter activity,219,0.333890106067624,1.43072771541074,0.00384615384615385,0.0495513070620367,0.0357311538698482,MF,mono-rr-vs-hc
GO:0016779,nucleotidyltransferase activity,120,-0.409231112067314,-1.63972476719319,0.00386100386100386,0.0495513070620367,0.0357311538698482,MF,mono-rr-vs-hc
GO:0022890,inorganic cation transmembrane transporter activity,340,0.321586901421454,1.44671041641914,0.00387596899224806,0.0495513070620367,0.0357311538698482,MF,mono-rr-vs-hc
GO:0016829,lyase activity,138,-0.38305099953138,-1.58663180705697,0.00389105058365759,0.0495513070620367,0.0357311538698482,MF,mono-rr-vs-hc
GO:0046873,metal ion transmembrane transporter activity,253,0.330270007550052,1.43391909525191,0.00389105058365759,0.0495513070620367,0.0357311538698482,MF,mono-rr-vs-hc
GO:0005509,calcium ion binding,416,0.285728790227674,1.3225038995617,0.004,0.0495513070620367,0.0357311538698482,MF,mono-rr-vs-hc
GO:0005057,receptor signaling protein activity,129,0.383662929322002,1.54951583541826,0.00418410041841004,0.0495513070620367,0.0357311538698482,MF,mono-rr-vs-hc
GO:0003682,chromatin binding,385,0.322606157331034,1.49756857448288,0.00423728813559322,0.0495513070620367,0.0357311538698482,MF,mono-rr-vs-hc
GO:0019903,protein phosphatase binding,111,0.40852703537608,1.61445262098981,0.00425531914893617,0.0495513070620367,0.0357311538698482,MF,mono-rr-vs-hc
GO:0019902,phosphatase binding,149,0.373601579964383,1.55227078652137,0.00429184549356223,0.0495513070620367,0.0357311538698482,MF,mono-rr-vs-hc
GO:0034660,ncRNA metabolic process,452,-0.370121746563943,-1.72033058779826,0.00333333333333333,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0006310,DNA recombination,264,-0.323679620956126,-1.43178156870444,0.00355871886120996,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0042770,signal transduction in response to DNA damage,120,-0.387103506859476,-1.54951842067193,0.0036101083032491,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0043241,protein complex disassembly,290,-0.350680825315796,-1.57126638277892,0.0036101083032491,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0090305,nucleic acid phosphodiester bond hydrolysis,229,-0.380720466057147,-1.64074130357809,0.0036101083032491,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0034470,ncRNA processing,318,-0.384591355157776,-1.72814354965044,0.0036231884057971,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0071356,cellular response to tumor necrosis factor,214,-0.339221215517539,-1.46401428264449,0.0036231884057971,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0043624,cellular protein complex disassembly,262,-0.348684984942648,-1.54665098281689,0.00364963503649635,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0030330,DNA damage response, signal transduction by p53 class mediator,104,-0.400613334536368,-1.58166511657151,0.00366300366300366,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0032984,macromolecular complex disassembly,301,-0.347760852321844,-1.56185725786326,0.00366300366300366,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0008033,tRNA processing,140,-0.425289539212597,-1.74239047810671,0.00367647058823529,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0022613,ribonucleoprotein complex biogenesis,361,-0.336413100037637,-1.54285103652572,0.00367647058823529,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0043900,regulation of multi-organism process,420,-0.305840201731815,-1.40631946874816,0.00367647058823529,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0043687,post-translational protein modification,425,-0.294513498872746,-1.35455510526591,0.003690036900369,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0098542,defense response to other organism,409,-0.363608311131577,-1.67059448699728,0.0037037037037037,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0016072,rRNA metabolic process,154,-0.391236429447382,-1.62471362896222,0.00371747211895911,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:1901991,negative regulation of mitotic cell cycle phase transition,163,-0.391321598831775,-1.66834516525631,0.00371747211895911,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0044772,mitotic cell cycle phase transition,443,-0.294587156747937,-1.3598873243169,0.00373134328358209,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0030178,negative regulation of Wnt signaling pathway,151,-0.373426203553968,-1.56490896160749,0.00374531835205993,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0030203,glycosaminoglycan metabolic process,131,0.362601342760481,1.47242135389631,0.00374531835205993,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0044770,cell cycle phase transition,458,-0.290294375391276,-1.34158731625195,0.00374531835205993,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0006364,rRNA processing,150,-0.393343213676655,-1.6234603651192,0.0037593984962406,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0006399,tRNA metabolic process,190,-0.437407203768771,-1.84720190444329,0.0037593984962406,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0031397,negative regulation of protein ubiquitination,143,-0.474247616040696,-1.91673158516826,0.00378787878787879,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0090090,negative regulation of canonical Wnt signaling pathway,128,-0.38888035905763,-1.57987955844137,0.00378787878787879,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:1903320,regulation of protein modification by small protein conjugation or removal,279,-0.344327326455078,-1.51650988477501,0.00378787878787879,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0016050,vesicle organization,249,-0.345784430916095,-1.52585064078777,0.00380228136882129,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0031396,regulation of protein ubiquitination,259,-0.323325828658199,-1.41672050156744,0.00380228136882129,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0006413,translational initiation,262,-0.334267391221279,-1.47821566375556,0.00381679389312977,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0016331,morphogenesis of embryonic epithelium,112,0.395238333706813,1.58992784912765,0.00381679389312977,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0051607,defense response to virus,275,-0.396026712524415,-1.74684210428935,0.00381679389312977,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:1903321,negative regulation of protein modification by small protein conjugation or removal,151,-0.473656125546032,-1.93208268291676,0.00381679389312977,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0033209,tumor necrosis factor-mediated signaling pathway,156,-0.389631035058235,-1.62140515326586,0.00383141762452107,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0042254,ribosome biogenesis,224,-0.406450447135339,-1.76306331152273,0.00383141762452107,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0043903,regulation of symbiosis, encompassing mutualism through parasitism,209,-0.358597728030737,-1.52069108810619,0.00383141762452107,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0044774,mitotic DNA integrity checkpoint,104,-0.464808005003218,-1.83417932859718,0.00383141762452107,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0051340,regulation of ligase activity,129,-0.488728540555769,-1.97075007607083,0.00383141762452107,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0072331,signal transduction by p53 class mediator,155,-0.37779681412482,-1.55941874481798,0.00383141762452107,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0070925,organelle assembly,493,-0.28718737322637,-1.33894823687303,0.00384615384615385,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0006289,nucleotide-excision repair,115,-0.405512864441279,-1.5993536445136,0.00386100386100386,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0001763,morphogenesis of a branching structure,135,0.396808475736439,1.64471384438711,0.00387596899224806,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0009451,RNA modification,116,-0.441366225289035,-1.7478878138495,0.00389105058365759,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0009743,response to carbohydrate,167,0.36559568205142,1.55630203021768,0.00389105058365759,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0050851,antigen receptor-mediated signaling pathway,194,-0.347712600078311,-1.48528036674433,0.00389105058365759,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0009615,response to virus,345,-0.349370837393676,-1.57614444942424,0.00390625,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:1901988,negative regulation of cell cycle phase transition,169,-0.374370585892946,-1.57848250073967,0.00390625,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0050792,regulation of viral process,185,-0.349749057289228,-1.47001443789083,0.00392156862745098,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0060538,skeletal muscle organ development,115,0.397764729066061,1.55043782685029,0.00392156862745098,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0071222,cellular response to lipopolysaccharide,139,0.375053661103877,1.54662090448075,0.00392156862745098,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0002429,immune response-activating cell surface receptor signaling pathway,298,-0.320701169531471,-1.43196113786003,0.00393700787401575,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:1903900,regulation of viral life cycle,173,-0.369660149577005,-1.54014673189078,0.00393700787401575,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0009749,response to glucose,138,0.366132845205676,1.50117503237323,0.00395256916996047,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0042692,muscle cell differentiation,257,0.35483860281091,1.57302769165216,0.00396825396825397,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0007093,mitotic cell cycle checkpoint,168,-0.382266034855445,-1.61401208475338,0.00398406374501992,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0001678,cellular glucose homeostasis,101,0.425367994726115,1.6566617721252,0.004,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0002009,morphogenesis of an epithelium,339,0.321200549229646,1.47486684120528,0.004,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0030073,insulin secretion,160,0.397635372330765,1.67201516406992,0.004,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0048638,regulation of developmental growth,219,0.334472388617366,1.44281932463826,0.004,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0035148,tube formation,109,0.401420817813352,1.58277753688801,0.00401606425702811,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0051056,regulation of small GTPase mediated signal transduction,245,0.332295270826856,1.47321771328199,0.00401606425702811,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0051438,regulation of ubiquitin-protein transferase activity,129,-0.457000237690725,-1.82042707474422,0.00401606425702811,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:1903522,regulation of blood circulation,196,0.354483694625586,1.51241338698987,0.00401606425702811,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0050796,regulation of insulin secretion,140,0.407409678472837,1.67100647124569,0.00403225806451613,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0001101,response to acid chemical,243,0.335843634092398,1.47851408879128,0.00404858299595142,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0006414,translational elongation,203,-0.397143375003494,-1.67811948212651,0.00404858299595142,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0006415,translational termination,177,-0.408721856470131,-1.70587417438013,0.0040650406504065,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0046578,regulation of Ras protein signal transduction,162,0.362509221470835,1.52391225357222,0.0040650406504065,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0061061,muscle structure development,401,0.334514912151095,1.53451992048047,0.0040650406504065,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0030198,extracellular matrix organization,247,0.35108950594059,1.54456922222829,0.00408163265306122,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0032543,mitochondrial translation,113,-0.536878406806815,-2.14428229166487,0.00408163265306122,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0051188,cofactor biosynthetic process,143,-0.358512093409363,-1.45244754202234,0.00408163265306122,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0061138,morphogenesis of a branching epithelium,124,0.369674173755732,1.51172131182381,0.00408163265306122,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0090276,regulation of peptide hormone secretion,158,0.362743124746768,1.50585814229787,0.00408163265306122,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0030072,peptide hormone secretion,188,0.344557388909283,1.47354825984875,0.00409836065573771,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0034329,cell junction assembly,185,0.358619159609068,1.51854420812326,0.00409836065573771,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0048511,rhythmic process,241,0.363746213006234,1.57236989249486,0.00409836065573771,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0048514,blood vessel morphogenesis,368,0.320452883475064,1.45267491225404,0.00409836065573771,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0006897,endocytosis,497,0.289532613652175,1.35316635533773,0.00411522633744856,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0043062,extracellular structure organization,248,0.347261045095228,1.52578339295513,0.00411522633744856,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0048598,embryonic morphogenesis,397,0.375536191319319,1.74185909555251,0.00411522633744856,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0009914,hormone transport,228,0.329948244453482,1.44587729952956,0.00413223140495868,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0023061,signal release,301,0.299836261864606,1.35905992279977,0.00413223140495868,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0046883,regulation of hormone secretion,191,0.341502365304134,1.4645064750979,0.00413223140495868,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0071229,cellular response to acid chemical,136,0.389936198732373,1.58669691398143,0.00413223140495868,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0001568,blood vessel development,439,0.330420190773362,1.53192548544447,0.004149377593361,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0007507,heart development,373,0.318276073302737,1.45644429523356,0.004149377593361,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0006112,energy reserve metabolic process,136,0.369294184602355,1.49199662977048,0.00418410041841004,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0046879,hormone secretion,223,0.331608385131753,1.45004484396288,0.00418410041841004,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:1902532,negative regulation of intracellular signal transduction,373,0.312791733747852,1.41642230053752,0.00418410041841004,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0006354,DNA-templated transcription, elongation,127,-0.399407878142211,-1.58502871167979,0.00420168067226891,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0010975,regulation of neuron projection development,291,0.317804088218191,1.42065737344,0.00420168067226891,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0033500,carbohydrate homeostasis,165,0.388610718389434,1.62012879284555,0.00420168067226891,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0042593,glucose homeostasis,165,0.388610718389434,1.62012879284555,0.00420168067226891,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:1901654,response to ketone,138,0.41035228233416,1.65291316940458,0.00420168067226891,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0002064,epithelial cell development,163,0.384032151893147,1.61807171231249,0.00421940928270042,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0006109,regulation of carbohydrate metabolic process,135,0.360707375720807,1.47541114798031,0.00421940928270042,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0010675,regulation of cellular carbohydrate metabolic process,127,0.374882697432023,1.52898701237223,0.00421940928270042,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0035264,multicellular organism growth,122,0.38129775796188,1.56055552762488,0.00421940928270042,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0002790,peptide secretion,193,0.355879931672599,1.520481042726,0.00423728813559322,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0007600,sensory perception,334,0.326460781542895,1.47447055357644,0.00423728813559322,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0007623,circadian rhythm,152,0.448310202535609,1.82933196231019,0.00423728813559322,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0048545,response to steroid hormone,396,0.293580507380722,1.35936726041811,0.00423728813559322,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0060541,respiratory system development,162,0.376655820076677,1.59769610470014,0.00423728813559322,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0001701,in utero embryonic development,294,0.320225380738447,1.44229549267445,0.00427350427350427,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0048568,embryonic organ development,288,0.324993197140941,1.46027432621209,0.00427350427350427,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0045664,regulation of neuron differentiation,389,0.321375776665309,1.48096536535942,0.00429184549356223,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0030029,actin filament-based process,498,0.278792870486851,1.32671529818016,0.00432900432900433,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0030855,epithelial cell differentiation,381,0.305311319734798,1.41656215927659,0.00434782608695652,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0043434,response to peptide hormone,491,0.273470587694802,1.29535478897404,0.00434782608695652,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0043627,response to estrogen,161,0.332659700683471,1.38006438109451,0.00436681222707424,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0048608,reproductive structure development,314,0.309635753371834,1.40118892745947,0.00436681222707424,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0003006,developmental process involved in reproduction,442,0.288327801168883,1.35134148147314,0.0043859649122807,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0061458,reproductive system development,318,0.309232488386782,1.40398596281398,0.0043859649122807,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0001944,vasculature development,459,0.334845223156014,1.55188274464923,0.00442477876106195,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0009792,embryo development ending in birth or egg hatching,458,0.303265282913672,1.41359023675188,0.00442477876106195,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0048589,developmental growth,429,0.294976756468683,1.3692040698386,0.00442477876106195,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0050767,regulation of neurogenesis,470,0.295439856625096,1.38492426891037,0.00442477876106195,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0043009,chordate embryonic development,453,0.302414789439814,1.41011848604606,0.00444444444444444,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0061448,connective tissue development,150,0.356302662932447,1.49153644036472,0.00444444444444444,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0006814,sodium ion transport,124,0.342700659594064,1.39702813242256,0.00448430493273543,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0001501,skeletal system development,308,0.326046624315028,1.49058983838582,0.00454545454545455,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0040008,regulation of growth,490,0.300977662479017,1.39890273985196,0.0045662100456621,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0051216,cartilage development,112,0.407105127121311,1.65323292733328,0.0045662100456621,0.0402049225971712,0.0279404380200976,BP,mono-rr-vs-hc
GO:0071396,cellular response to lipid,417,0.322695228387288,1.50199056072156,0.00460829493087558,0.0402482533075665,0.0279705507264519,BP,mono-rr-vs-hc
GO:0071407,cellular response to organic cyclic compound,410,0.312617173426196,1.46593628327141,0.00480769230769231,0.0416538461538462,0.0289473684210526,BP,mono-rr-vs-hc
GO:1901987,regulation of cell cycle phase transition,262,-0.314989387341572,-1.3957952936616,0.0072992700729927,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0002253,activation of immune response,472,-0.28959426605909,-1.35349476247781,0.00738007380073801,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0031960,response to corticosteroid,123,0.386754783756681,1.54946433880574,0.0075187969924812,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0000723,telomere maintenance,122,-0.357912960529845,-1.41446510173046,0.00754716981132075,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:1903050,regulation of proteolysis involved in cellular protein catabolic process,234,-0.330758329393468,-1.42741688471947,0.00754716981132075,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0002757,immune response-activating signal transduction,433,-0.290419941875596,-1.34300816727729,0.00757575757575758,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0034284,response to monosaccharide,147,0.357409398774943,1.49480402699538,0.00757575757575758,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0060537,muscle tissue development,234,0.329242334811433,1.43009007533769,0.00757575757575758,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:1901990,regulation of mitotic cell cycle phase transition,250,-0.321850047977719,-1.41558525848909,0.00757575757575758,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0009746,response to hexose,141,0.356009325701489,1.4753445983083,0.00763358778625954,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0006900,membrane budding,117,-0.398780532353337,-1.60403637275818,0.00766283524904215,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0051186,cofactor metabolic process,311,-0.312470290872981,-1.38875590353519,0.00766283524904215,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0051384,response to glucocorticoid,118,0.404479453910361,1.60462389259855,0.00766283524904215,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0002263,cell activation involved in immune response,176,-0.323915065335684,-1.37650314416761,0.00772200772200772,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0061025,membrane fusion,142,-0.371572333269446,-1.52713359510373,0.00772200772200772,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,197,-0.30490348855483,-1.31430357222525,0.00775193798449612,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:1903362,regulation of cellular protein catabolic process,251,-0.325143704773565,-1.40811723866503,0.00775193798449612,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0006487,protein N-linked glycosylation,237,-0.304539688220245,-1.33560903876016,0.0078125,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0007519,skeletal muscle tissue development,110,0.37727950668512,1.46343330519723,0.00784313725490196,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0048729,tissue morphogenesis,426,0.300627947644382,1.39842588203422,0.00784313725490196,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0050852,T cell receptor signaling pathway,160,-0.367415607456678,-1.53704980109294,0.00784313725490196,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0001525,angiogenesis,316,0.296470810273242,1.32668549220375,0.00790513833992095,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0007423,sensory organ development,345,0.302031051859709,1.3854742426794,0.00793650793650794,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0071156,regulation of cell cycle arrest,103,-0.391858868499177,-1.53902562514664,0.00793650793650794,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0002474,antigen processing and presentation of peptide antigen via MHC class I,102,-0.389044138120089,-1.52703983053773,0.00796812749003984,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0006457,protein folding,198,-0.338842649298582,-1.44656509206131,0.008,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0031570,DNA integrity checkpoint,156,-0.364262506587763,-1.51448761042776,0.008,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0048193,Golgi vesicle transport,296,-0.30307839788976,-1.34577270159734,0.008,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0051146,striated muscle cell differentiation,175,0.34081528258932,1.42943884464928,0.008,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0030324,lung development,140,0.363900329910922,1.51627392167702,0.00803212851405622,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0008360,regulation of cell shape,112,0.373640778369071,1.51508249287156,0.00806451612903226,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0071322,cellular response to carbohydrate stimulus,105,0.377559974031499,1.48462062172473,0.00806451612903226,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0030100,regulation of endocytosis,165,0.361067179909181,1.50884143833538,0.00809716599190283,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0071219,cellular response to molecule of bacterial origin,146,0.346639221853182,1.44036132138597,0.00809716599190283,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0018279,protein N-linked glycosylation via asparagine,229,-0.307039450061653,-1.33125777893135,0.00813008130081301,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0002791,regulation of peptide secretion,161,0.358063206117627,1.48812867418653,0.00816326530612245,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0018196,peptidyl-asparagine modification,230,-0.303920064825394,-1.31919273874818,0.00819672131147541,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0030323,respiratory tube development,144,0.364865803082621,1.52530198249711,0.00819672131147541,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0032355,response to estradiol,106,0.384604226196917,1.50678525692882,0.00819672131147541,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0015833,peptide transport,248,0.319711739075677,1.41125938920581,0.00823045267489712,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0050890,cognition,175,0.324421685830888,1.37097261564086,0.00823045267489712,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0071804,cellular potassium ion transport,104,0.368034402091359,1.43677160355845,0.00829875518672199,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0071805,potassium ion transmembrane transport,104,0.368034402091359,1.43677160355845,0.00829875518672199,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0035637,multicellular organismal signaling,119,0.382280698054402,1.5337410863337,0.00833333333333333,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0036293,response to decreased oxygen levels,240,0.32335145830905,1.40967604653066,0.00833333333333333,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0071216,cellular response to biotic stimulus,163,0.337968529368528,1.43166548613226,0.00833333333333333,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0071456,cellular response to hypoxia,109,0.426987084663808,1.69216692986307,0.00836820083682008,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0007389,pattern specification process,260,0.303623132710911,1.35974809592924,0.00840336134453781,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0098662,inorganic cation transmembrane transport,444,0.279722333701683,1.31155540912393,0.00840336134453781,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0036294,cellular response to decreased oxygen levels,116,0.40478452009855,1.60917653364543,0.00851063829787234,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0097305,response to alcohol,269,0.31465737597218,1.38132464541691,0.00851063829787234,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0071241,cellular response to inorganic substance,127,0.341913370986602,1.36597180996914,0.00854700854700855,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0098655,cation transmembrane transport,485,0.281580124226476,1.32437909632043,0.00854700854700855,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0008544,epidermis development,179,0.348655044694511,1.48839566898929,0.00858369098712446,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0044057,regulation of system process,337,0.292066932514705,1.31861067390939,0.00858369098712446,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0071453,cellular response to oxygen levels,123,0.392763952413529,1.56152355283824,0.00858369098712446,0.0513598748014132,0.0356925795626286,BP,mono-rr-vs-hc
GO:0006417,regulation of translation,292,0.299535801968274,1.34572680200282,0.00865800865800866,0.0515199086627658,0.0358037952022914,BP,mono-rr-vs-hc
GO:0015672,monovalent inorganic cation transport,379,0.271283636210477,1.26101466765877,0.0091324200913242,0.0540459615240662,0.0375592773384918,BP,mono-rr-vs-hc
GO:0031349,positive regulation of defense response,383,-0.286343031780355,-1.31281435089636,0.0106761565836299,0.0628384651090825,0.0436696336229713,BP,mono-rr-vs-hc
GO:0034612,response to tumor necrosis factor,234,-0.318376807218942,-1.38775753234707,0.0109090909090909,0.0638624078624079,0.0443812233285918,BP,mono-rr-vs-hc
GO:0007051,spindle organization,121,-0.372512302400577,-1.50065414539337,0.0112781954887218,0.0647340107591154,0.0449869443483185,BP,mono-rr-vs-hc
GO:0032200,telomere organization,134,-0.339087415361682,-1.35966995392924,0.0112781954887218,0.0647340107591154,0.0449869443483185,BP,mono-rr-vs-hc
GO:0050663,cytokine secretion,144,-0.360885804384128,-1.46507108601738,0.0113207547169811,0.0647340107591154,0.0449869443483185,BP,mono-rr-vs-hc
GO:0006022,aminoglycan metabolic process,136,0.351717023364598,1.42948357797185,0.0113636363636364,0.0647340107591154,0.0449869443483185,BP,mono-rr-vs-hc
GO:1903364,positive regulation of cellular protein catabolic process,175,-0.341618377864874,-1.44565990675288,0.0113636363636364,0.0647340107591154,0.0449869443483185,BP,mono-rr-vs-hc
GO:0034341,response to interferon-gamma,138,-0.346354795874905,-1.41750154739476,0.0114503816793893,0.0647340107591154,0.0449869443483185,BP,mono-rr-vs-hc
GO:0045862,positive regulation of proteolysis,327,-0.314586347501337,-1.40585619331488,0.0114942528735632,0.0647340107591154,0.0449869443483185,BP,mono-rr-vs-hc
GO:0002274,myeloid leukocyte activation,138,-0.346536754238381,-1.39217870972214,0.0116731517509728,0.0647340107591154,0.0449869443483185,BP,mono-rr-vs-hc
GO:0014706,striated muscle tissue development,226,0.331846833554929,1.42616809155783,0.0116731517509728,0.0647340107591154,0.0449869443483185,BP,mono-rr-vs-hc
GO:0034330,cell junction organization,206,0.329526961973033,1.42860065783777,0.01171875,0.0647340107591154,0.0449869443483185,BP,mono-rr-vs-hc
GO:0044801,single-organism membrane fusion,117,-0.387866323345751,-1.53714591442112,0.0117647058823529,0.0647340107591154,0.0449869443483185,BP,mono-rr-vs-hc
GO:0031344,regulation of cell projection organization,395,0.271398953595873,1.25630617883175,0.0119047619047619,0.0647340107591154,0.0449869443483185,BP,mono-rr-vs-hc
GO:1902115,regulation of organelle assembly,108,-0.393408084175866,-1.54841560859732,0.0119047619047619,0.0647340107591154,0.0449869443483185,BP,mono-rr-vs-hc
GO:0048284,organelle fusion,113,-0.372924510951648,-1.4725240208345,0.012,0.0647340107591154,0.0449869443483185,BP,mono-rr-vs-hc
GO:0002250,adaptive immune response,299,-0.291158617275059,-1.30321690649842,0.0120481927710843,0.0647340107591154,0.0449869443483185,BP,mono-rr-vs-hc
GO:0070482,response to oxygen levels,253,0.315319929186327,1.39112686559095,0.0120967741935484,0.0647340107591154,0.0449869443483185,BP,mono-rr-vs-hc
GO:0042886,amide transport,265,0.306518014988319,1.36628429872287,0.0121951219512195,0.0647340107591154,0.0449869443483185,BP,mono-rr-vs-hc
GO:0008016,regulation of heart contraction,149,0.363143075325361,1.49446816115441,0.0122448979591837,0.0647340107591154,0.0449869443483185,BP,mono-rr-vs-hc
GO:0000077,DNA damage checkpoint,148,-0.364680425373566,-1.49593655552927,0.0122950819672131,0.0647340107591154,0.0449869443483185,BP,mono-rr-vs-hc
GO:0022604,regulation of cell morphogenesis,403,0.271178115001515,1.26165195851642,0.0122950819672131,0.0647340107591154,0.0449869443483185,BP,mono-rr-vs-hc
GO:0060047,heart contraction,172,0.339995596782485,1.42979971632075,0.012396694214876,0.0647340107591154,0.0449869443483185,BP,mono-rr-vs-hc
GO:0007179,transforming growth factor beta receptor signaling pathway,172,0.337069907391678,1.41761993173635,0.012448132780083,0.0647340107591154,0.0449869443483185,BP,mono-rr-vs-hc
GO:0060485,mesenchyme development,155,0.340524072826009,1.41491359230287,0.0125,0.0647340107591154,0.0449869443483185,BP,mono-rr-vs-hc
GO:0001666,response to hypoxia,232,0.329469252719744,1.4315085118974,0.0125523012552301,0.0647340107591154,0.0449869443483185,BP,mono-rr-vs-hc
GO:0042391,regulation of membrane potential,227,0.299650348063029,1.31638050337332,0.0125523012552301,0.0647340107591154,0.0449869443483185,BP,mono-rr-vs-hc
GO:0003015,heart process,173,0.3398611485836,1.42130847082888,0.0127118644067797,0.0650971749148467,0.0452393255227831,BP,mono-rr-vs-hc
GO:0071560,cellular response to transforming growth factor beta stimulus,204,0.297074678527093,1.26475109780883,0.0128755364806867,0.0650971749148467,0.0452393255227831,BP,mono-rr-vs-hc
GO:0071559,response to transforming growth factor beta,207,0.318581386822696,1.36162754283915,0.0129310344827586,0.0650971749148467,0.0452393255227831,BP,mono-rr-vs-hc
GO:0098660,inorganic ion transmembrane transport,485,0.277649205886791,1.31062049796029,0.012987012987013,0.0650971749148467,0.0452393255227831,BP,mono-rr-vs-hc
GO:1901653,cellular response to peptide,431,0.269325930209543,1.26103131230808,0.012987012987013,0.0650971749148467,0.0452393255227831,BP,mono-rr-vs-hc
GO:0032409,regulation of transporter activity,143,0.356434610489443,1.46351671471682,0.0130434782608696,0.0650971749148467,0.0452393255227831,BP,mono-rr-vs-hc
GO:0035295,tube development,436,0.310345861700192,1.44083219584331,0.0130434782608696,0.0650971749148467,0.0452393255227831,BP,mono-rr-vs-hc
GO:0042493,response to drug,336,0.293915355266227,1.31949177096124,0.0140845070422535,0.0699702803979842,0.0486258934582871,BP,mono-rr-vs-hc
hsa04920,Adipocytokine signaling pathway,63,0.496588207833253,1.79234201196597,0.00359712230215827,0.0351689612015019,0.0237138528423688,KG,mono-rr-vs-hc
hsa04720,Long-term potentiation,52,0.524002947247309,1.81071758387502,0.00366300366300366,0.0351689612015019,0.0237138528423688,KG,mono-rr-vs-hc
hsa04261,Adrenergic signaling in cardiomyocytes,112,0.398475033277504,1.58858103743131,0.00374531835205993,0.0351689612015019,0.0237138528423688,KG,mono-rr-vs-hc
hsa05215,Prostate cancer,79,0.460978800241264,1.73614095807637,0.00383141762452107,0.0351689612015019,0.0237138528423688,KG,mono-rr-vs-hc
hsa04152,AMPK signaling pathway,112,0.392289768622166,1.58436212528394,0.00384615384615385,0.0351689612015019,0.0237138528423688,KG,mono-rr-vs-hc
hsa04917,Prolactin signaling pathway,62,0.503748041762903,1.7787362096825,0.00384615384615385,0.0351689612015019,0.0237138528423688,KG,mono-rr-vs-hc
hsa04912,GnRH signaling pathway,73,0.435581798306456,1.59966383188314,0.00387596899224806,0.0351689612015019,0.0237138528423688,KG,mono-rr-vs-hc
hsa04623,Cytosolic DNA-sensing pathway,48,-0.498581283631254,-1.68285287930061,0.00390625,0.0351689612015019,0.0237138528423688,KG,mono-rr-vs-hc
hsa04931,Insulin resistance,96,0.419584323941258,1.58496563515902,0.00390625,0.0351689612015019,0.0237138528423688,KG,mono-rr-vs-hc
hsa04730,Long-term depression,48,0.479422862935463,1.63052101571294,0.00392156862745098,0.0351689612015019,0.0237138528423688,KG,mono-rr-vs-hc
hsa05202,Transcriptional misregulation in cancer,147,0.365855243100481,1.49863952914873,0.00395256916996047,0.0351689612015019,0.0237138528423688,KG,mono-rr-vs-hc
hsa04550,Signaling pathways regulating pluripotency of stem cells,103,0.408866664350034,1.6059675387885,0.00396825396825397,0.0351689612015019,0.0237138528423688,KG,mono-rr-vs-hc
hsa04726,Serotonergic synapse,72,0.49628972456186,1.83294219752648,0.00396825396825397,0.0351689612015019,0.0237138528423688,KG,mono-rr-vs-hc
hsa04728,Dopaminergic synapse,94,0.456576671261528,1.76839414998162,0.00398406374501992,0.0351689612015019,0.0237138528423688,KG,mono-rr-vs-hc
hsa04022,cGMP-PKG signaling pathway,125,0.386196126927627,1.54801522285455,0.004,0.0351689612015019,0.0237138528423688,KG,mono-rr-vs-hc
hsa04911,Insulin secretion,55,0.450510738513055,1.58319868313747,0.00401606425702811,0.0351689612015019,0.0237138528423688,KG,mono-rr-vs-hc
hsa04918,Thyroid hormone synthesis,59,0.532649351975651,1.88498489348835,0.00401606425702811,0.0351689612015019,0.0237138528423688,KG,mono-rr-vs-hc
hsa05146,Amoebiasis,75,0.463615676798539,1.75631726551784,0.00401606425702811,0.0351689612015019,0.0237138528423688,KG,mono-rr-vs-hc
hsa00830,Retinol metabolism,25,-0.589206236860015,-1.8120499590625,0.00403225806451613,0.0351689612015019,0.0237138528423688,KG,mono-rr-vs-hc
hsa03420,Nucleotide excision repair,45,-0.513866881862694,-1.72192176039834,0.00404858299595142,0.0351689612015019,0.0237138528423688,KG,mono-rr-vs-hc
hsa04015,Rap1 signaling pathway,163,0.346872878985805,1.43676413660037,0.00404858299595142,0.0351689612015019,0.0237138528423688,KG,mono-rr-vs-hc
hsa04510,Focal adhesion,156,0.378633871111261,1.56896550652591,0.00404858299595142,0.0351689612015019,0.0237138528423688,KG,mono-rr-vs-hc
hsa04713,Circadian entrainment,65,0.427465810485191,1.52201701290312,0.00404858299595142,0.0351689612015019,0.0237138528423688,KG,mono-rr-vs-hc
hsa05032,Morphine addiction,57,0.511409946702874,1.80988592446073,0.0040650406504065,0.0351689612015019,0.0237138528423688,KG,mono-rr-vs-hc
hsa04919,Thyroid hormone signaling pathway,108,0.471254172811112,1.85395849829802,0.00408163265306122,0.0351689612015019,0.0237138528423688,KG,mono-rr-vs-hc
hsa04723,Retrograde endocannabinoid signaling,62,0.531151004824686,1.8969847707975,0.00413223140495868,0.0351689612015019,0.0237138528423688,KG,mono-rr-vs-hc
hsa04972,Pancreatic secretion,58,0.515733913564252,1.79907644071139,0.00413223140495868,0.0351689612015019,0.0237138528423688,KG,mono-rr-vs-hc
hsa04750,Inflammatory mediator regulation of TRP channels,76,0.44288707110288,1.66680907848762,0.004149377593361,0.0351689612015019,0.0237138528423688,KG,mono-rr-vs-hc
hsa04810,Regulation of actin cytoskeleton,166,0.368080780840004,1.54832038638861,0.004149377593361,0.0351689612015019,0.0237138528423688,KG,mono-rr-vs-hc
hsa05200,Pathways in cancer,318,0.301638259739227,1.3462063422287,0.00416666666666667,0.0351689612015019,0.0237138528423688,KG,mono-rr-vs-hc
hsa04970,Salivary secretion,58,0.495066405860088,1.75479137362396,0.00418410041841004,0.0351689612015019,0.0237138528423688,KG,mono-rr-vs-hc
hsa05206,MicroRNAs in cancer,132,0.452671699053328,1.82967118748444,0.00420168067226891,0.0351689612015019,0.0237138528423688,KG,mono-rr-vs-hc
hsa03050,Proteasome,43,-0.608423186749802,-2.04803913350729,0.00423728813559322,0.0351689612015019,0.0237138528423688,KG,mono-rr-vs-hc
hsa04024,cAMP signaling pathway,140,0.389787938708177,1.60103883236976,0.00425531914893617,0.0351689612015019,0.0237138528423688,KG,mono-rr-vs-hc
hsa05205,Proteoglycans in cancer,165,0.345599550671224,1.44841263450375,0.00446428571428571,0.035479797979798,0.0239234449760766,KG,mono-rr-vs-hc
hsa03008,Ribosome biogenesis in eukaryotes,70,-0.528975074734893,-1.89568916255834,0.00454545454545455,0.035479797979798,0.0239234449760766,KG,mono-rr-vs-hc
hsa05160,Hepatitis C,103,0.392704260026104,1.51809205779526,0.00706713780918728,0.0449779911964786,0.030327920641941,KG,mono-rr-vs-hc
hsa04068,FoxO signaling pathway,123,0.3976406352379,1.60176471119497,0.00716845878136201,0.0449779911964786,0.030327920641941,KG,mono-rr-vs-hc
hsa04910,Insulin signaling pathway,119,0.390857870802698,1.54961474280431,0.00727272727272727,0.0449779911964786,0.030327920641941,KG,mono-rr-vs-hc
hsa00020,Citrate cycle (TCA cycle),27,-0.570840580266507,-1.71378161638665,0.00743494423791822,0.0449779911964786,0.030327920641941,KG,mono-rr-vs-hc
hsa04380,Osteoclast differentiation,126,0.367874918128617,1.47294795809262,0.00754716981132075,0.0449779911964786,0.030327920641941,KG,mono-rr-vs-hc
hsa04260,Cardiac muscle contraction,52,0.434111348321549,1.55549279391523,0.00757575757575758,0.0449779911964786,0.030327920641941,KG,mono-rr-vs-hc
hsa05134,Legionellosis,53,-0.477731725319171,-1.66038448360665,0.00760456273764259,0.0449779911964786,0.030327920641941,KG,mono-rr-vs-hc
hsa05340,Primary immunodeficiency,33,-0.594616857103504,-1.85200261330938,0.00769230769230769,0.0449779911964786,0.030327920641941,KG,mono-rr-vs-hc
hsa05219,Bladder cancer,37,0.503840291477322,1.63722935375759,0.00778210116731518,0.0449779911964786,0.030327920641941,KG,mono-rr-vs-hc
hsa04922,Glucagon signaling pathway,81,0.437764824284796,1.62495595494697,0.008,0.0449779911964786,0.030327920641941,KG,mono-rr-vs-hc
hsa05034,Alcoholism,132,0.380601082978172,1.55448664365667,0.008,0.0449779911964786,0.030327920641941,KG,mono-rr-vs-hc
hsa04150,mTOR signaling pathway,58,0.424380481040483,1.50635986974879,0.00806451612903226,0.0449779911964786,0.030327920641941,KG,mono-rr-vs-hc
hsa04010,MAPK signaling pathway,201,0.337873772672847,1.4299643589081,0.00809716599190283,0.0449779911964786,0.030327920641941,KG,mono-rr-vs-hc
hsa04725,Cholinergic synapse,81,0.422290158573841,1.56359251360328,0.00813008130081301,0.0449779911964786,0.030327920641941,KG,mono-rr-vs-hc
hsa04966,Collecting duct acid secretion,22,-0.609149965131188,-1.74755712687028,0.00816326530612245,0.0449779911964786,0.030327920641941,KG,mono-rr-vs-hc
hsa04924,Renin secretion,42,0.507214699522406,1.67357594772424,0.00840336134453781,0.0454104718810601,0.0306195352634981,KG,mono-rr-vs-hc
hsa00240,Pyrimidine metabolism,97,-0.37216303063765,-1.44303532483412,0.0108695652173913,0.0573820706555034,0.0386917876680675,KG,mono-rr-vs-hc
hsa04062,Chemokine signaling pathway,156,0.331874746064159,1.3910686545288,0.0111940298507463,0.0573820706555034,0.0386917876680675,KG,mono-rr-vs-hc
hsa04722,Neurotrophin signaling pathway,105,0.411856358361217,1.61556821622664,0.0113636363636364,0.0573820706555034,0.0386917876680675,KG,mono-rr-vs-hc
hsa04146,Peroxisome,75,-0.416650361646314,-1.55090001579597,0.0115384615384615,0.0573820706555034,0.0386917876680675,KG,mono-rr-vs-hc
hsa04611,Platelet activation,103,0.387663356713345,1.50597629877463,0.0119047619047619,0.0573820706555034,0.0386917876680675,KG,mono-rr-vs-hc
hsa04540,Gap junction,64,0.447082918897151,1.61448181923276,0.012,0.0573820706555034,0.0386917876680675,KG,mono-rr-vs-hc
hsa04724,Glutamatergic synapse,79,0.410341070326052,1.51284861016922,0.0120481927710843,0.0573820706555034,0.0386917876680675,KG,mono-rr-vs-hc
hsa04961,Endocrine and other factor-regulated calcium reabsorption,41,0.473151366862671,1.57318078724254,0.0122950819672131,0.0575819672131148,0.0388265746333046,KG,mono-rr-vs-hc
hsa03430,Mismatch repair,23,-0.585277056751273,-1.70865781516256,0.0126582278481013,0.0576134499726627,0.0388478029409226,KG,mono-rr-vs-hc
hsa02010,ABC transporters,33,0.502194805048658,1.5817482623256,0.0127118644067797,0.0576134499726627,0.0388478029409226,KG,mono-rr-vs-hc
hsa00970,Aminoacyl-tRNA biosynthesis,43,-0.453098763674973,-1.54359144510697,0.0146520146520147,0.0653526367812082,0.0440662094797433,KG,mono-rr-vs-hc
hsa01200,Carbon metabolism,95,-0.392587687220428,-1.48284554446265,0.0152671755725191,0.0670324427480916,0.045198875050221,KG,mono-rr-vs-hc
hsa03030,DNA replication,36,-0.498346631913926,-1.59051918654752,0.015748031496063,0.067919511752976,0.0457970111089555,KG,mono-rr-vs-hc
hsa04020,Calcium signaling pathway,124,0.340595844922623,1.36799351404639,0.016,0.067919511752976,0.0457970111089555,KG,mono-rr-vs-hc
hsa04151,PI3K-Akt signaling pathway,245,0.299379155484295,1.30121672678475,0.0161943319838057,0.067919511752976,0.0457970111089555,KG,mono-rr-vs-hc
hsa04662,B cell receptor signaling pathway,69,0.378732337195516,1.39027195990661,0.017921146953405,0.074056504322159,0.0499350843902926,KG,mono-rr-vs-hc
